High Tower Advisors, LLC Athenex, Inc. Transaction History

High Tower Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.41 - $0.91 $55,461 - $123,098	135,273 Added 15.71%	996,513 $408,000
Q4 2021 Feb 10, 2022	BUY	$1.36 - $2.94 $544,000 - $1.18 Million	400,000 Added 86.72%	861,240 $1.17 Million
Q3 2021 Nov 12, 2021	BUY	$2.97 - $4.84 $297,041 - $484,067	100,014 Added 27.69%	461,240 $1.39 Million
Q1 2021 May 10, 2021	SELL	$4.08 - $14.75 $7,164 - $25,901	-1,756 Reduced 0.48%	361,226 $1.55 Million
Q4 2020 Feb 10, 2021	SELL	$11.06 - $14.01 $15,484 - $19,614	-1,400 Reduced 0.38%	362,982 $4.02 Million
Q3 2020 Nov 13, 2020	BUY	$10.26 - $14.55 $52,069 - $73,841	5,075 Added 1.41%	364,382 $4.41 Million
Q2 2020 Aug 10, 2020	SELL	$7.11 - $13.76 $1,066 - $2,064	-150 Reduced 0.04%	359,307 $4.94 Million
Q1 2020 May 21, 2020	BUY	$5.71 - $15.85 $856 - $2,377	150 Added 0.04%	359,457 $2.78 Million
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $48,000 - $88,750	-5,000 Reduced 1.37%	359,307 $5.49 Million
Q2 2019 Aug 13, 2019	SELL	$9.44 - $19.8 $1,888 - $3,960	-200 Reduced 0.05%	364,307 $7.21 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $13.49 $3.28 Million - $3.98 Million	295,200 Added 425.93%	364,507 $4.47 Million
Q3 2018 Nov 09, 2018	BUY	$15.53 - $19.97 $1.08 Million - $1.38 Million	69,307 New	69,307 $1.08 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.